All About The 'Space Bug' Lurking And Mutating In International Space Station

rohit rohit | 06-12 00:12

Scientists aboard the International Space Station (ISS) have detected a “mutating bug” capable of affecting the well-being of astronauts who venture into space.

This multi-drug resistant bacteria, dubbed ‘Enterobacter bugandensis,’ has evolved within the closed environment of the ISS, posing potential health risks to the stationed astronauts, including Indian-origin astronaut Sunita Williams, who is part of Boeing’s Starliner capsule.

What’s The Space Bug About

Despite ISS’ highly controlled environment, characterised by microgravity, increased CO2 levels, and elevated solar radiation, microorganisms occupy a unique niche.

One microorganism of particular interest is Enterobacter bugandensis, primarily found in clinical specimens including the human gastrointestinal tract, and also reported to possess pathogenic traits, leading to a plethora of infections.

NASA

What We Know

Recent findings funded by an Ames Space Biology grant and led by Dr. Kasthuri Venkateswaran of NASA’s Jet Propulsion Laboratory revealed the presence of thirteen strains of the notorious E. bugandensis, known for its resistance to multiple drugs.

These strains, isolated from the ISS, have displayed a troubling tendency to mutate and become genetically and functionally distinct compared to their Earth counterparts, indicating adaptation to the unique conditions of space. Collaborative research efforts between the Indian Institute of Technology (IIT) Madras and NASA’s Jet Propulsion Laboratory have shed light on the behavior and evolution of this space bug, according to several reports.

Boeing Starliner spacecraft prepares to dock with the International Space Station for the first time on Thursday, June 6, 2024. (NASA via AP)

Implications

The study, published in the scientific journal Microbiome, underscores the microbial dynamics in extreme environments like the ISS and stresses the need for robust preventive measures to safeguard astronaut health. The implications of these findings are profound.

On one hand, they provide insights into microbial adaptation and evolution in isolated environments subjected to microgravity, radiation, and elevated carbon dioxide levels. On the other hand, they highlight the urgency of implementing effective preventive measures to mitigate the risks associated with potential pathogenic threats in space habitats.

Boeing’s Starliner capsule atop an Atlas V rocket lifts off from Space Launch Complex 41 at the Cape Canaveral Space Force Station on a mission to the International Space Station, Wednesday, June 5, 2024, in Cape Canaveral, Fla. (AP Photo/John Raoux)

NASA’s acknowledgment of the unique challenges posed by closed human-built environments like the ISS reinforces the importance of understanding microbial dynamics for ensuring astronaut health and safety.

By delving into the interplay between microorganisms and extreme environments, this research aims to pave the way for innovative preventive strategies to protect astronauts during prolonged space missions.

Despite the challenges posed by the presence of space bugs, NASA scientists continue their mission aboard the ISS, supported by ongoing research efforts aimed at understanding and mitigating potential health risks associated with microbial threats in space.

About the Author
Rohit
Rohit is sub-editor at News18.com and covers international news. He previously worked with Asian News International (ANI). He is interested in world a...Read More

Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.


ALSO READ

China's Zeekr launches EV in Australia, eyes New Zealand next

Chinese EV maker Zeekr's has begun sales of its first model for Australia. Chinese EV maker Zeekr's ...

Hyundai is for the long haul and do not expect to make quick buck on listing: Dipan Mehta

Dipan Mehta, Director, Elixir Equities.Dipan Mehta, Director, Elixir Equities, says Hyundai compares...

EV chipmaker Wolfspeed set to receive USD 750 million US chips grant

Wolfspeed's devices are used for renewable energy systems, industrial uses and artificial intelligen...

Rio Tinto Q3 iron ore shipments rise, Simandou on track for 2025

Rio said iron ore production from its Iron Ore Company of Canada (IOC) operations fell 11% following...

Hyundai issue is for long-term investors; expect 16-18% growth in next 2-3 yrs: Narendra Solanki

Narendra Solanki, Head Fundamental Research-Investment Services, Anand Rathi Shares & Stock Brok...

Electric car sales have slumped, misinformation is one of the reasons

The politicisation of green initiatives adds to the challenge. When electric vehicles become associa...